Ironwood Pharma Reiterated at Sell and 3 Reiterated Ratings Not To Miss

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on December 18th.

CarMax (NYSE:KMX): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $38 to $41.

Ironwood Pharma (NASDAQ:IRWD): Cantor Fitzgerald reiterated its rating of Sell for this company and changed its price target from $7 to $8.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Cardiovascular Systems (NASDAQ:CSII): The Benchmark Company reiterated its rating of Speculative Buy for this company and changed its price target from $13.5 to $18.

National Financial Partners (NYSE:NFP): William Blair reiterated its rating of Outperform for this company.

Don’t Miss: Fiscal Cliff: New Chapter, Same Story.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business